Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components

Area of Science:

• Pulmonary Pathology
• Cancer Genomics
• Tumor Biology

Background:

• Combined small cell lung carcinomas (CSCLCs) feature both small cell lung carcinoma (SCLC) and non-small cell components.
• These mixed tumors represent a significant subset of SCLC cases, impacting diagnosis and treatment.
• Understanding the relationship between the distinct morphologic areas is crucial for elucidating tumor origin and behavior.

Purpose of the Study:

• To investigate the immunophenotypic and genotypic similarities between the morphologically distinct components within CSCLCs.
• To determine if the different cellular elements within a single CSCLC arise from a common progenitor.
• To clarify the biological relationship of CSCLCs to pure SCLC.

Main Methods:

• Immunohistochemical staining for markers including synaptophysin, CD56, chromogranin, bcl-2, TTF-1, cytokeratin 7, and PAX-5 on 7 CSCLC cases.
• Loss of heterozygosity (LOH) analysis using genetic markers on chromosomes 3p, 17p, 17q, and 22q.
• Comparative analysis of marker expression and LOH patterns between SCLC and non-SCLC components within each tumor.

Main Results:

• Identical immunophenotypes were observed in the distinct components of 6 out of 7 CSCLC cases.
• Both SCLC and non-SCLC components consistently expressed synaptophysin and CD56.
• Shared loss of heterozygosity (LOH) at one or more loci was detected in all analyzed tumors, with 5 cases showing LOH at 22q13, a characteristic SCLC marker.

Conclusions:

• The distinct morphologic components within combined small cell lung carcinomas are generally closely related at the immunophenotypic and genotypic levels.
• The shared expression of SCLC markers (synaptophysin, CD56) and common LOH patterns suggest a shared origin or clonal relationship.
• These findings support the classification of CSCLCs as biologically closer to small cell lung carcinomas.